We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+14.5%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$59B
AUM Growth
+$9.67B
(+20%)
Cap. Flow
+$3.02B
Cap. Flow
% of AUM
5.11%
Top 10 Holdings %
Top 10 Hldgs %
26.45%
Holding
2,790
New
663
Increased
538
Reduced
776
Closed
680
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.43B |
| 2 |
Amazon
AMZN
|
+$601M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$414M |
| 4 |
D.R. Horton
DHI
|
+$305M |
| 5 |
Intel
INTC
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$905M |
| 2 |
NVIDIA
NVDA
|
+$592M |
| 3 |
Advanced Micro Devices
AMD
|
+$439M |
| 4 |
Amgen
AMGN
|
+$385M |
| 5 |
Adobe
ADBE
|
+$382M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.79% |
| 2 | Consumer Discretionary | 13.23% |
| 3 | Healthcare | 12.61% |
| 4 | Financials | 7.44% |
| 5 | Communication Services | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RYZB
1001
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| $3.66M | 0.01% |
58,800
-293,178
| -83% | -$7.29M |
|
|
ACAHW
1002
CALL
DELISTED
Atlantic Coastal Acquisition Corp. Warrant
ACAHW
| $3.65M | 0.01% |
345,868
-15,553
| -4% | -$393 |
|
1003
TaskUs
TASK
$531M
| $3.63M | 0.01% |
+277,776
| New | +$3.08M |
|
1004
Petrobras Class A
PBR.A
$103B
| $3.62M | 0.01% |
237,027
+130,147
| +122% | +$1.87M |
|
|
ACH
1005
Accendra Health
ACH
$247M
| $3.62M | 0.01% |
187,905
-327,447
| -64% | -$5.93M |
|
|
BFAC.WS
1006
CALL
DELISTED
Battery Future Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
BFAC.WS
| $3.62M | 0.01% |
330,975
-40,000
| -11% | -$2.78K |
|
1007
Jazz Pharmaceuticals
JAZZ
$16B
| $3.6M | 0.01% |
+29,235
| New | +$3.65M |
|
|
KRTX
1008
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $3.6M | 0.01% |
+11,359
| New | +$2.21M |
|
1009
Matrix Service
MTRX
$347M
| $3.59M | 0.01% |
367,391
+117,545
| +47% | +$1.28M |
|
1010
Knife River
KNF
$4.46B
| $3.57M | 0.01% |
+53,994
| New | +$3.07M |
|
1011
Scholastic
SCHL
$752M
| $3.55M | 0.01% |
+94,152
| New | +$3.6M |
|
1012
Bread Financial
BFH
$4.29B
| $3.54M | 0.01% |
107,507
+39,193
| +57% | +$1.17M |
|
1013
SS&C Technologies
SSNC
$18.1B
| $3.53M | 0.01% |
+57,748
| New | +$3.15M |
|
1014
C3.ai
AI
$1.37B
| $3.51M | 0.01% |
122,300
+83,900
| +218% | +$2.31M |
|
1015
Coherent
COHR
$53.1B
| $3.5M | 0.01% |
80,448
-203,622
| -72% | -$7.34M |
|
1016
8x8 Inc
EGHT
$262M
| $3.5M | 0.01% |
+926,206
| New | +$2.75M |
|
|
WCN
1017
Waste Connections
WCN
$42.7B
| $3.5M | 0.01% |
23,452
-30,692
| -57% | -$4.22M |
|
1018
Ciena
CIEN
$53.4B
| $3.5M | 0.01% |
+77,691
| New | +$3.43M |
|
1019
Biomea Fusion
BMEA
$91.1M
| $3.48M | 0.01% |
+239,539
| New | +$2.91M |
|
1020
Lemonade
LMND
$4.76B
| $3.46M | 0.01% |
214,453
+74,694
| +53% | +$1.13M |
|
1021
Stock Yards Bancorp
SYBT
$2.43B
| $3.43M | 0.01% |
66,685
-52,358
| -44% | -$2.33M |
|
|
TGH
1022
DELISTED
Textainer Group Holdings limited
TGH
| $3.42M | 0.01% |
+69,584
| New | +$3.2M |
|
1023
Pennant Group
PNTG
$1.44B
| $3.41M | 0.01% |
245,277
-85,894
| -26% | -$1.07M |
|
1024
Fulcrum Therapeutics
FULC
$249M
| $3.41M | 0.01% |
505,102
-543,544
| -52% | -$2.41M |
|
1025
Palomar
PLMR
$3.73B
| $3.39M | 0.01% |
61,050
-32,623
| -35% | -$1.82M |
|
Similar funds
Marshall Wace's Q4 2023 Portfolio in Review
As of Q4 2023, Marshall Wace held 2,790 positions worth $59B, up 20% from $49.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Marshall Wace deployed $3.02B of net new capital in Q4 2023, opening 663 new positions and adding to 538 existing holdings. Its largest new stake was Qualcomm: 1,674,985 shares worth $242M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $905M trimmed.
- Marshall Wace's largest Q4 2023 buy was Qualcomm: 1,674,985 shares worth $242M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $3.43B increase.
- Marshall Wace's biggest Q4 2023 reduction was Microsoft, cutting an estimated $905M.
- Marshall Wace fully exited VMware, Inc in Q4 2023, selling an estimated $149M.
- Marshall Wace's ten largest holdings make up 26% of its $59B portfolio in Q4 2023.
- Marshall Wace opened 663 new positions and closed 680 in Q4 2023.
- Marshall Wace's portfolio value rose 20% quarter-over-quarter to $59B.
Based on Marshall Wace's 13F filing for Q4 2023, filed 14 Feb 2024.